Go6976 is a novel and potent inhibitor of JAK2 and JAK3 tyrosine kinases both in vitro and in cellular assays

被引:0
|
作者
Grandage, VL [1 ]
Linch, DC [1 ]
Khwaja, A [1 ]
机构
[1] UCL Royal Free & UCL Med Sch, Dept Haematol, London, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
15
引用
收藏
页码:6 / 6
页数:1
相关论文
共 50 条
  • [21] Optimization of a novel kinase inhibitor scaffold for the dual inhibition of JAK2 and FAK kinases
    Zificsak, Craig A.
    Gingrich, Diane E.
    Breslin, Henry J.
    Dunn, Derek D.
    Milkiewicz, Karen L.
    Theroff, Jay P.
    Thieu, Tho V.
    Underiner, Ted L.
    Weinberg, Linda R.
    Aimone, Lisa D.
    Albom, Mark S.
    Mason, Jennifer L.
    Saville, Lisa
    Husten, Jean
    Angeles, Thelma S.
    Finn, James P.
    Jan, Mahfuza
    O'Kane, Teresa M.
    Dobrzanski, Pawel
    Dorsey, Bruce D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (01) : 133 - 137
  • [22] AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders
    Dawson, Mark A.
    Curry, Jayne E.
    Barber, Kelly
    Beer, Philip A.
    Graham, Brent
    Lyons, John F.
    Richardson, Caroline J.
    Scott, Mike A.
    Smyth, Tomoko
    Squires, Matthew S.
    Thompson, Neil T.
    Green, Anthony R.
    Wallis, Nicola G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (01) : 46 - 57
  • [23] Effects of CYT387, a Potent Novel JAK2 Inhibitor on JAK2-V617F Induced MPD
    Bumm, Thomas G. P.
    Tyner, Jeffrey W.
    Deininger, Jutta
    Loriaux, Marc
    VanDyke, Jonathan
    Druker, Brian J.
    Burns, Christopher J.
    Fantino, Emmanuelle
    Deininger, Michael W. N.
    BLOOD, 2008, 112 (11) : 316 - 317
  • [24] Z3, a novel Jak2 tyrosine kinase small-molecule inhibitor that suppresses Jak2-mediated pathologic cell growth
    Sayyah, Jacqueline
    Magis, Andrew
    Ostrov, David A.
    Allan, Robert W.
    Braylan, Raul C.
    Sayeski, Peter P.
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (08) : 2308 - 2318
  • [25] Identification of a novel inhibitor of JAK2 tyrosine kinase by structure-based virtual screening
    Robert Kiss
    Timea Polgar
    Kirabo, Annet
    Sayyah, Jacqueline
    Figueroa, Nicholas C.
    List, Alan F.
    Sokol, Lubomir
    Zuckerman, Kenneth S.
    Gali, Meghanath
    Bisht, Kirpal S.
    Sayeski, Peter P.
    Keseru, Gyorgy M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (13) : 3598 - 3601
  • [26] A selective and potent oral inhibitor of the JAK2 tyrosine kinase reverses polycythemia and leukocytosis induced by JAK2V617F in a mouse model
    Zaleskas, Virginia M.
    Chan, Wayne W.
    Evangelista, Peter
    Lazarides, Katherine
    Chopra, Rajesh
    Zinda, Michael
    Huszar, Dennis
    Van Etten, Richard A.
    BLOOD, 2007, 110 (11) : 171A - 171A
  • [27] Discovery of CPL-407-22-Novel, Potent and Highly Selective JAK2 Kinase Inhibitor
    Dzwonek, K.
    Mroczkiewicz, M.
    Stefaniak, F.
    Gunerka, P.
    Zdzalik, D.
    Dymek, B.
    Grygielewicz, P.
    Lamparska-Przybysz, M.
    Wieczorek, M.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 120 - 120
  • [28] PACRITINIB Inhibitor of Tyrosine-Protein Kinase JAK2 Inhibitor of FLT-3 Treatment of Myelofibrosis
    Verstovsek, S.
    Machida, C.
    Dean, J. P.
    Myint, H.
    DRUGS OF THE FUTURE, 2013, 38 (06) : 375 - 386
  • [29] NS-018, a Potent Novel JAK2 Inhibitor, Effectively Treats Murine MPN Induced by the Janus Kinase 2 (JAK2) V617F Mutant
    Shide, Kotaro
    Nakaya, Yohei
    Kameda, Takuro
    Shimoda, Haruko
    Hidaka, Tomonori
    Kubuki, Yoko
    Katayose, Keiko
    Matsunaga, Takuya
    Homan, Junko
    Kotera, Takashi
    Shibayama, Hiroshi
    Naito, Haruna
    Shimoda, Kazuya
    BLOOD, 2010, 116 (21) : 1671 - 1672
  • [30] JAK2 inhibitor blocks the inflammation and development of esophageal squamous carcinoma in vitro through JAK/STAT3 signaling pathway
    Fang, J.
    Chu, L.
    Li, C.
    Hu, F.
    Zhang, X.
    Chen, Y.
    Zhao, H.
    Xu, Q.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S581 - S581